Eyelid surgery Surgical site infection Eyelid surgery Surgical site infection Postoperative oral antibiotic
Conditions
Interventions
Dicloxacillin(250mg) contained in opaque capsule
Sig. 1 cap PO q.i.d. ac x 7 days ,Cornstarch capsule (250mg) contained in opaque capsule identical to Antibiotic capsule.
Sig. 1 cap PO q.i.d. ac x 7
Experimental Drug,Placebo Comparator Drug
Oral Antibiotic,Oral Placebo
Sponsors
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who underwent eyelid surgery at Ramathibodi hospital by Dr.Pornchai Mahaisavariya
Exclusion criteria
Exclusion criteria: 1. Patients who request to withdraw from study 2. History of any Penicillin,Cloxacillin,Dicloxacillin allergy. 3. Presentation of any sign of inflammation or infection at surgical site prior to surgery. 4. Patient who dose not complete 1 month follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical site infection rate at 1 week, 1 month after operation Direct examination by investigator, using CDC superficial surgical site infection criteria | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical wound complication at 1 week, 1 month after operation Direct examination by investigator,Drug adherence at 1 week after operation Patient reported outcome using a questionnaire interview,Drug complication at 1 week after operation Patient reported outcome using a questionnaire interview | — |
Countries
Thailand
Contacts
Public ContactThanidon Boonwittaya
Ramathibodi Hospital, Mahidol University
Outcome results
None listed